InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Explore the detailed record of transactions filed by Violin Jonathan, Director. Director active across 2 companies, notably Astria Therapeutics, Inc.. Cumulatively, 10 filings have been logged. Split: 0 buy · 6 sells. Total volume traded: €2.1m. Activity tracked since 20 September 2021. The latest transaction was filed on 1 June 2022 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations10 total
30,000 shares@ US$12.200.020% mcap16.8% of flowCommon StockSEC:0000899243-22-020717:0
30,000 shares@ US$13.040.021% mcap18.2% of flowCommon StockSEC:0000899243-22-016657:0
26,400 shares@ US$18.920.026% mcap22.0% of flowCommon StockSEC:0000899243-22-013858:0
18,894 shares@ US$17.820.017% mcap14.6% of flowCommon StockSEC:0000899243-22-009096:0
16,751 shares@ US$19.550.017% mcap14.2% of flowCommon StockSEC:0000899243-22-004665:0
16,751 shares@ US$19.550.017% mcap100.0% of flowCommon StockSEC:0000899243-22-004665
627,564 shares0Common StockSEC:0000899243-21-047801
627,564 shares0Common StockSEC:0000899243-21-047801:0
263,321 shares0Common StockSEC:0001104659-21-118359:0
263,321 shares0Common StockSEC:0001104659-21-118359
10 of 10 declarations
About Violin Jonathan
Jonathan Violin is the President and Director at Astria Therapeutics, Inc. and Viridian Therapeutics, Inc. He plays a key role in the strategic direction of these companies, overseeing operations and the development of new products. Jonathan contributes to guiding research and development initiatives.
